Lars Boesgaard
Chief Financial Officer · PDS Biotechnology Corp
Individual
- 2025
- Mar 3, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Lars Boesgaard's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lars Boesgaard?
Lars Boesgaard is a corporate insider, tracked as Chief Financial Officer of PDS Biotechnology Corp (PDSB). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lars Boesgaard last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 2 filings going back to 2025.